JPMorgan analyst Andrea Teixeira lowered the firm’s price target on Clorox (CLX) to $127 from $135 and keeps a Neutral rating on the shares as part of a Q3 preview for the household, personal care and beauty group. Most of these large cap companies in the group will likely report another weak quarter amid “still depressed” consumer demand in the U.S. and decelerating trends for Western Europe, the analyst tells investors in a research note. JPMorgan says this backdrop is further worsened by retailers taking down inventory.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLX: